Comparison of Efficacy of Two Combination Regimens for the Neisseria

Status Completed

Clinical Trial Summary

The frequency of Chlamydia trachomatis and Neisseria gonorrhoeae coinfection can vary depending on their individual incidence and prevalence rates.Single-agent therapy with ceftriaxone is the preferred regimen for treatment of gonococcal infections. If an injectable cephalosporin is not available, cefixime is the only oral cephalosporin that can be used for gonococcal therapy. Doxycycline was recommended for presumptive treatment of chlamydia in nonpregnant individuals with gonococcal infection. The study is conducted to evaluate the effectiveness of two regimens in combination with doxycycline with cefixime or ceftriaxone.

Clinical Trial Description

Gonococcal infections, including urethritis, cervicitis, epididymitis, and proctitis, are a significant cause of morbidity among sexually active men and women. The treatment of these sexually transmitted infections (STIs) has evolved over the years, mainly due to the emergence of antibiotic resistance. The frequency of Chlamydia trachomatis and Neisseria gonorrhoeae coinfection can vary depending on their individual incidence and prevalence rates. Ceftriaxone is highly effective against susceptible N. gonorrhoeae. Single-agent therapy with ceftriaxone is the preferred regimen for treatment of gonococcal infections. These doses of ceftriaxone are higher than previously recommended due to concerns regarding rising gonococcal minimum inhibitory concentrations (MICs) worldwide. If an injectable cephalosporin is not available, cefixime is the only oral cephalosporin that can be used for gonococcal therapy. Doxycycline (100 mg orally twice daily for seven days) was recommended for presumptive treatment of chlamydia in nonpregnant individuals with gonococcal infection. The study is conducted to evaluate the effectiveness of two regimens in combination with doxycycline with cefixime or ceftriaxone. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05216744
Study type	Interventional
Source	Haiphong University of Medicine and Pharmacy
Contact
Status	Completed
Phase	Phase 2
Start date	July 15, 2021
Completion date	February 20, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04269434` - GonoScreen: Efficacy of Screening STIs in MSM	N/A
Active, not recruiting	`NCT04139629` - Cohort Study Investigating the Association Between Antichlamydial Antibody Positivity and ART Outcomes in Women With TFI	N/A
Completed	`NCT03107377` - Phase 2B/3 Double-blinded Placebo-controlled	Phase 2/Phase 3
Completed	`NCT03098329` - Check it: A New Approach to Controlling Chlamydia Transmission in Young People	N/A
Recruiting	`NCT03862495` - Genital CT Treatment to Pregnant Women to Prevent Adverse Pregnancy Outcomes: A Pilot RCT	N/A
Completed	`NCT05307991` - Integrating Enhanced HIV PrEP Into a STI Clinic in Lilongwe
Terminated	`NCT02083276` - Mecillinam for Treatment of Genital Chlamydia Infection	Phase 2
Active, not recruiting	`NCT06131749` - Genital Tract Infections, the Vaginal Microbiome and Gestational Age at Birth Among Pregnant Women in South Africa
Completed	`NCT03568695` - Detection of Chlamydia Trachomatis, Neisseria Gonorrhoeae and Mycoplasma Genitalium by Real-time Multiplex Polymerase Chain Reaction (PCR) After Pooling Pharyngeal, Anorectal and Urinary Samples	N/A
Completed	`NCT01448876` - Incubation Time and Test of Cure of Chlamydia Trachomatis	N/A
Not yet recruiting	`NCT06369220` - A Study of the Cobas® Liat CT/NG/MG Test Versus Current Standard Practice for Managing Participants at Increased Risk of Sexually Transmitted Infections	N/A
Not yet recruiting	`NCT06395675` - Clinical Evaluation of the ID NOW™ CT/NG Test	N/A
Completed	`NCT03970850` - NeuMoDx PrEDiCTiNG Study Evaluation Plan	N/A
Completed	`NCT01631201` - Safety and Efficacy Study of Rifalazil for the Treatment of Chlamydia Trachomatis Infection in Women	Phase 2
Recruiting	`NCT05581160` - Assess the Performance of Metagenomic Sequencing in the Diagnosis of STI (NGS-IST)	N/A
Not yet recruiting	`NCT03532464` - Azithromycin Compared With Doxycycline for Treating Anorectal Chlamydia Trachomatis Infection Concomitant to a Vaginal Infection	Phase 4
Not yet recruiting	`NCT06234943` - Pharmacy-based Testing and Treatment for Gonorrhea and Chlamydia	N/A
Active, not recruiting	`NCT04050540` - Doxycycline PEP for Prevention of Sexually Transmitted Infections Among Kenyan Women Using HIV PrEP	Phase 4
Completed	`NCT04955717` - Antenatal Chlamydia Trachomatis and Neisseria Gonorrhoeae Testing to Prevent Adverse Neonatal Consequences	N/A
Recruiting	`NCT05666778` - Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIs	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Comparison of Efficacy of Two Combination Regimens for the Neisseria Gonorrhoeae and Chlamydia Coinfection

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms